DOI QR코드

DOI QR Code

Resveratrol Inhibits Oesophageal Adenocarcinoma Cell Proliferation via AMP-activated Protein Kinase Signaling

  • Fan, Guang-Hua (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University) ;
  • Wang, Zhong-Ming (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University) ;
  • Yang, Xi (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University) ;
  • Xu, Li-Ping (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University) ;
  • Qin, Qin (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University) ;
  • Zhang, Chi (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University) ;
  • Ma, Jian-Xin (Department of Radiation oncology, Lianyungang Second People's Hospital) ;
  • Cheng, Hong-Yan (Department of Synthetic Internal Medicine, the First Affiliated Hospital of Nanjing Medical University) ;
  • Sun, Xin-Chen (Department of Radiation Oncology, the First Affiliated Hospital of Nanjing Medical University)
  • 발행 : 2014.01.30

초록

Resveratrol has been examined in several model systems for potential effects against cancer. Adenosine monophosphate-activated protein kinase (AMPK) is reported to suppress proliferation in most eukaryocyte cells. Whether resveratrol via AMPK inhibits proliferation of oesophageal adenocarcinoma cells (OAC) is unknown. The aim of this study was to determine the roles of AMPK in the protective effects of resveratrol in OAC proliferation and to elucidate the underlying mechanisms. Treatment of cultured OAC derived from human subjects or cell lines with resveratrol resulted in decreased cell proliferation. Further, inhibition of AMPK by pharmacological reagent or genetical approach abolished resveratrol-suppressed OAC proliferation, reduced the level of $p27^{Kip1}$, a cyclin-dependent kinase inhibitor, and increased the levels of S-phase kinase-associated protein 2 (Skp2) of $p27^{Kip1}$-E3 ubiquitin ligase and 26S proteasome activity reduced by resveratrol. Furthermore, gene silencing of $p27^{Kip1}$ reversed resveratrol-suppressed OAC proliferation. In conclusion, these findings indicate that resveratrol inhibits Skp2-mediated ubiquitylation and 26S proteasome-dependent degradation of $p27^{Kip1}$ via AMPK activation to suppress OAC proliferation.

키워드

참고문헌

  1. Baur JA, Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov, 5, 493-506. https://doi.org/10.1038/nrd2060
  2. Bishayee A, Dhir N (2009). Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact, 179, 131-44. https://doi.org/10.1016/j.cbi.2008.11.015
  3. Boehm M, Olive M, True AL, et al (2004). Bone marrow-derived immune cells regulate vascular disease through a p27 (Kip1)-dependent mechanism. J Clin Invest, 114, 419-26. https://doi.org/10.1172/JCI200420176
  4. Cal C, Garban H, Jazirehi A, et al (2003). Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anticancer Agents, 3, 77-93. https://doi.org/10.2174/1568011033353443
  5. Cimino S, Sortino G, Favilla V, et al (2012). Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev, 2012, 632959.
  6. Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA, 104, 7217-22. https://doi.org/10.1073/pnas.0610068104
  7. Engel K, Bassermann F (2013). The ubiquitin proteasome system and its implications for oncology. Dtsch Med Wochenschr, 138, 1178-82. https://doi.org/10.1055/s-0033-1343110
  8. Faber AC, Dufort FJ, Blair D, et al (2006). Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochem Pharmacol, 72, 1246-56. https://doi.org/10.1016/j.bcp.2006.08.009
  9. Jang M, Cai L, Udeani GO, et al (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-20. https://doi.org/10.1126/science.275.5297.218
  10. Jiang W, Zhu Z, Thompson HJ (2008). Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res, 68, 5492-9. https://doi.org/10.1158/0008-5472.CAN-07-6721
  11. Kiselev KV (2011). Perspectives for production and application of resveratrol. Appl Microbiol Biotechnol, 90, 417-425. https://doi.org/10.1007/s00253-011-3184-8
  12. Kleiger G, Saha A, Lewis S, Kuhlman B, Deshaies RJ (2009). Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates. Cell, 139, 957-68. https://doi.org/10.1016/j.cell.2009.10.030
  13. Liang J, Shao SH, Xu ZX, et al (2007). The energy sensing LKB1-AMPK pathway regulates p27 (kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol, 9, 218-24. https://doi.org/10.1038/ncb1537
  14. Liu M, Wilk SA, Wang A, et al (2010). Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J Biol Chem, 285, 36387-94. https://doi.org/10.1074/jbc.M110.169284
  15. Nagata D, Takeda R, Sata M, et al (2004). AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation, 110, 444-51. https://doi.org/10.1161/01.CIR.0000136025.96811.76
  16. Nakata R, Takahashi S, Inoue H (2012). Recent advances in the study on resveratrol. Biol Pharm Bull, 35, 273-9. https://doi.org/10.1248/bpb.35.273
  17. Neves AR, Lucio M, Lima JL, Reis S (2012). Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem, 19, 1663-81. https://doi.org/10.2174/092986712799945085
  18. Song P, Wang S, He C, et al (2011). AMPKalpha2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ Res, 109, 1230-9. https://doi.org/10.1161/CIRCRESAHA.111.250423
  19. Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K, Haslberger A (2012). Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention. Br J Pharmacol, 167, 279-97. https://doi.org/10.1111/j.1476-5381.2012.02002.x
  20. Storozhuk Y, Hopmans SN, Sanli T, et al (2013). Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J Cancer, 108, 2021-32. https://doi.org/10.1038/bjc.2013.187
  21. Tang Q LG, Wei X, Zhang J, et al (2013). Resveratrol- induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma. Cancer Lett, 336, 325-337. https://doi.org/10.1016/j.canlet.2013.03.023
  22. Wang B, Wang XB, Chen LY, Huang L, Dong RZ (2013). Belinostat-induced apoptosis and growth inhibition in pancreatic cancer cells involve activation of TAK1-AMPK signaling axis. Biochem Biophys Res Commun, 437, 1-6. https://doi.org/10.1016/j.bbrc.2013.05.090
  23. Wang S, Xu J, Song P, et al (2008). Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension, 52, 484-90. https://doi.org/10.1161/HYPERTENSIONAHA.108.112094
  24. Wang S, Zhang M, Liang B, et al (2010). AMPKalpha2 deletion causes aberrant expression and activation of NAD (P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res, 106, 1117-28. https://doi.org/10.1161/CIRCRESAHA.109.212530
  25. Weixel KM, Marciszyn A, Alzamora R, et al (2013). Resveratrol Inhibits the Epithelial Sodium Channel via Phopshoinositides and AMP-Activated Protein Kinase in Kidney Collecting Duct Cells. PLoS One, 8, e78019. https://doi.org/10.1371/journal.pone.0078019
  26. Whitlock NC, Baek SJ (2012). The anticancer effects of resveratrol: modulation of transcription factors. Nutr Cancer, 64, 493-502. https://doi.org/10.1080/01635581.2012.667862
  27. Woodall CE, Li Y, Liu QH, Wo J, Martin RC (2009). Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Anticancer Drugs, 20, 437-43. https://doi.org/10.1097/CAD.0b013e32832afb95
  28. Wu YJ, Sala-Newby GB, Shu KT, et al (2009). S-phase kinaseassociated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. J Vasc Surg, 50, 1135-42. https://doi.org/10.1016/j.jvs.2009.07.066
  29. Xu J, Wu Y, Song P, et al (2007). Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation, 116, 944-53. https://doi.org/10.1161/CIRCULATIONAHA.106.684795
  30. Zang Y, Yu LF, Nan FJ, Feng LY, Li J (2009). AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D. J Biol Chem, 284, 6175-84. https://doi.org/10.1074/jbc.M806887200
  31. Zhang M, Dong Y, Xu J, et al (2008). Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ Res, 102, 328-37. https://doi.org/10.1161/CIRCRESAHA.107.163253

피인용 문헌

  1. Saponins from Rubus parvifolius L. Induce Apoptosis in Human Chronic Myeloid Leukemia Cells through AMPK Activation and STAT3 Inhibition vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5455
  2. Targeting Cancer with Nano-Bullets: Curcumin, EGCG, Resveratrol and Quercetin on Flying Carpets vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3865
  3. Time - and Concentration - Dependent Effects of Resveratrol on miR 15a and miR16-1 Expression and Apoptosis in the CCRF-CEM Acute Lymphoblastic Leukemia Cell Line vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6463
  4. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down-Regulation of Skp2 in Pancreatic Cancer Cells vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3805
  5. Resveratrol as an anti-cancer agent: A review pp.1549-7852, 2018, https://doi.org/10.1080/10408398.2016.1263597
  6. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines pp.14765810, 2017, https://doi.org/10.1111/vco.12375
  7. Peanut consumption associated with a reduced risk of esophageal squamous cell carcinoma: A case-control study in a high-risk area in China pp.17597706, 2017, https://doi.org/10.1111/1759-7714.12520
  8. expression and apoptosis in a resveratrol- and prednisolone-treated human T-ALL cell line, CCRF-CEM vol.53, pp.1, 2018, https://doi.org/10.5045/br.2018.53.1.53